Balentine LLC’s CYTEC INDS INC CYT Stock Holding History

Balentine LLC’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-620	Closed	-$38K	–	494
2015 Q2	$38K	Sell	620 -290	-32%	-$16.9K	0.01%	187
2015 Q1	$49K	Buy	+910	New	+$45.4K	0.01%	142

Other funds holding CYT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Balentine LLC's CYT Position: Q3 2015 in Review

Balentine LLC sold out of CYTEC INDS INC (CYT) in Q3 2015, closing a stake of 620 shares — an estimated $38K sold.

Balentine LLC first reported a position in CYT in Q1 2015 and held it in 2 quarters. The position peaked at $49K in Q1 2015. 260 funds tracked by Wall St. Rank hold CYT as of Q3 2015.

Balentine LLC reported no remaining CYTEC INDS INC position as of Q3 2015 after selling out during the quarter.
Balentine LLC sold 620 CYTEC INDS INC shares in Q3 2015, an estimated $38K.
Balentine LLC first reported a position in CYTEC INDS INC in Q1 2015 and held it in 2 quarters.
Balentine LLC's CYTEC INDS INC position peaked at $49K in Q1 2015.
260 funds tracked by Wall St. Rank held CYTEC INDS INC as of Q3 2015.

Based on Balentine LLC's 13F filing for Q3 2015, filed 18 Nov 2015.